How to Inject Peptides: Sites, Technique, Pain, Rotation (With Diagrams)

Key takeaways

• Peptides are injected subcutaneously, into the fat under the skin, with a short, thin needle: 4 to 6 mm and 29 to 31 gauge is the standard for adults of any size.
• Three sites: the abdomen (2 inches from the navel), the front or outer thigh, and the back of the upper arm if someone else injects. The FDA labels for semaglutide and tirzepatide list the same three and say to rotate with every dose.
• Rotation is not optional. Repeated injections into one spot cause lipohypertrophy, found in about two-thirds of long-term insulin users in a large survey, and it is strongly linked to not rotating and to reusing needles.
• Most pain is avoidable: room-temperature solution, dry skin, a fresh needle, a quick insertion and a slow push.
• Mild redness, a small bruise or a drop of blood are normal. Spreading redness, warmth, pus, fever or hives are not: call your clinician.

Where to inject

Subcutaneous means into the layer of fat between the skin and the muscle. That layer exists almost everywhere, but three areas are used because they are easy to reach, have enough fat in most adults and have few nerves and large vessels near the surface.

The prescribing information for Wegovy (semaglutide) tells patients to "inject subcutaneously in the abdomen, thigh, or upper arm" and to "rotate injection sites with each dose"; the Zepbound (tirzepatide) label says the same, specifying that the upper-arm site is for when "another person" gives the injection. Those labels are the best-documented instructions for subcutaneous peptide injection in existence, and they apply equally to a compounded vial-and-syringe product.

Abdomen. The default site. Stay at least 2 inches (5 cm) away from the navel in every direction, above or below the belt line, and avoid the waistband crease where clothing rubs. Absorption from the abdomen is consistent, and most people find it the least painful site.

Thigh. The front or outer part of the middle third of the thigh. Avoid the inner thigh and the area just above the knee. Lean people have less fat here; a lifted skin fold prevents injecting into muscle.

Back of the upper arm. The fatty area on the back of the arm between shoulder and elbow. It is hard to reach yourself without bunching the skin incorrectly, which is why the labels reserve it for injections given by someone else.

Avoid any spot that is bruised, red, hard, lumpy, scarred, tattooed over recent ink, or within 2 inches of the navel.

Needle length and gauge

Insulin syringes and pen needles come in several lengths, and shorter is better. The international FITTER consensus on injection technique (Mayo Clinic Proceedings, 2016) concluded that 4 mm pen needles are suitable for all adults regardless of body size, that 6 mm is the shortest syringe needle available, and that the older 12.7 mm (half-inch) length should be avoided for most people because of the risk of injecting into muscle, especially in the thigh and in lean patients. Gauge is thickness, and higher is thinner: 31 G needles are the most comfortable for the watery solutions all peptides are.

Step by step: vial and insulin syringe

1. Wash your hands and lay out the vial, a new syringe, two alcohol swabs, a tissue and the sharps container.
2. Let the vial warm up. Take it out of the refrigerator 15 to 30 minutes before. Cold solution stings; it does not need to be warmed in any other way.
3. Check the vial. Name, concentration, beyond-use date; clear and colorless. If you have not confirmed your dose in units, do it now with the units guide or the calculator, and write it down.
4. Swab the stopper and let it dry.
5. Draw the dose. Pull the plunger to your dose to fill the syringe with air, push the needle through the stopper, inject the air into the vial, turn the vial upside down with the needle in the liquid, and pull the plunger slowly past your dose. Tap bubbles to the top and push them out until the top of the plunger sits exactly on your line.
6. Choose and clean the site. Pick the next spot in your rotation plan, swab it, and let the alcohol dry completely. Wet alcohol carried in by the needle is the main cause of stinging.
7. Insert. Hold the syringe like a pen. With a 4 to 6 mm needle, go straight in at 90 degrees with one quick, smooth motion; with a longer needle or very little fat, lift a fold of skin with your thumb and two fingers and inject into the fold. Do not push the needle in slowly.
8. Inject slowly. Press the plunger steadily over several seconds. Fast injection of even a small volume stretches the tissue and hurts.
9. Pause, then withdraw. Count to five, pull the needle straight out at the angle it went in, and release the fold.
10. Press, do not rub. Hold a tissue on the spot for a few seconds. Rubbing spreads the solution into tissue and bruises.
11. Dispose of the syringe in an FDA-cleared sharps container immediately, needle and all. Never recap, bend or reuse it.
12. Log the site (date and location), so the next injection goes somewhere else.

Pens and pre-filled syringes

Brand GLP-1 pens (Wegovy, Zepbound, Mounjaro, Ozempic) and some compounded products come pre-filled. The site selection, rotation and aftercare are identical. Follow the pen instructions for priming, hold the pen flat against the skin at 90 degrees, press and hold for the full count the instructions specify (6 to 10 seconds depending on the device) so the full dose is delivered, then dispose of the pen or needle as directed.

Rotation: the part people skip

Injecting into the same spot over and over produces lipohypertrophy: a rubbery, sometimes visible thickening of the fat under the skin. In a survey of 430 people injecting insulin, published in Diabetes and Metabolism in 2013, lipohypertrophy was present in 64.4%, and it was strongly associated with not rotating sites correctly and with reusing needles. Drug injected into these lumps is absorbed unpredictably, which for a GLP-1 means more side effects on some days and less effect on others. A 2026 international expert consensus on lipohypertrophy repeats the same two preventive measures: systematic rotation and a new needle for every injection.

A simple plan that works:

For a daily peptide, each injection moves at least 1 cm (half an inch) from the last, and in practice an inch is easier to judge; for a weekly GLP-1, simply alternate zones. Keep a note on your phone or the pharmacy calendar. If you find a lump, skip that area for a few months and tell your clinician.

Making it hurt less

• Temperature. Room-temperature solution. Never inject straight from the refrigerator.
• Dry skin. Let the alcohol evaporate fully.
• Fresh, thin, short needle. 31 G, 4 to 6 mm. A reused needle is visibly bent under magnification after one use.
• Speed. Fast in, slow push, straight out.
• Relax the area. A tense abdominal wall or thigh hurts more; breathe out as you insert.
• Volume. If your dose is more than 0.5 mL, ask the pharmacy whether a more concentrated reconstitution is possible; smaller volumes are more comfortable.
• Ice. Thirty seconds of ice on the spot before swabbing numbs the skin; it is optional and most people stop needing it.

What is normal, and what is not

Injection-site reactions are listed on every injectable peptide label. In the Wegovy weight-management trials, 1.4% of patients on semaglutide and 1% on placebo reported them (itching, redness, inflammation, hardening or irritation at the site). In the Zepbound trials they were more common, in 6 to 8% of patients at the 5 to 15 mg doses versus 2% on placebo, and markedly more common in the minority of patients who developed antibodies to tirzepatide (11.3% versus 1%). Compounded products, which can contain impurities the brand products do not, have no comparable data.

Normal, and needs nothing:

• A small bump or redness that fades within a day or two
• A drop of blood, a small bruise
• Mild itching at the site

Call your clinician the same day:

• Redness that spreads, warmth, swelling that grows, pus, or a fever: possible infection
• Hives, swelling of the face or lips, wheezing or trouble breathing: possible allergic reaction; call emergency services if breathing is affected
• A hard, painful lump that persists for more than a few days, or lumps appearing at multiple sites

Needles, sharps and the rest of the household

The CDC rule is one sterile syringe and needle per injection, and FDA asks that used sharps go immediately into an FDA-cleared sharps container (or, at minimum, a heavy-duty plastic container with a screw lid, labeled, never a glass or recyclable bottle). Keep vials and syringes away from children and pets, and never share a vial, even with a partner on the same medication: a vial that has been entered with someone else's needle is no longer yours.

Bottom line

Short needle, three sites, rotate every time, fresh syringe every time, warm solution and dry skin. Done that way, a subcutaneous peptide injection takes a minute and is close to painless. The two habits that cause most of the trouble, reusing needles and returning to the same spot, are the two easiest to fix.

Frequently asked questions

+−Where is the best place to inject peptides?

The abdomen, at least 2 inches (5 cm) from the navel, is the most used site: it is easy to reach, has a reliable layer of fat and tends to hurt least. The front or outer thigh is the usual second site. The back of the upper arm works only when another person gives the injection. The FDA labels for the GLP-1 drugs list exactly these three areas and instruct patients to rotate sites with each dose.

+−Do peptide injections hurt?

Usually very little. The needles are 29 to 31 gauge and 4 to 8 mm long, and most people describe a pinch or nothing. Pain comes from cold solution, wet alcohol on the skin, a slow insertion, a reused or long needle, and injecting into muscle. The volume matters too; doses under 0.5 mL are the most comfortable.

+−Can I inject peptides into muscle?

Peptides prescribed for subcutaneous use should be injected under the skin, not into muscle. Intramuscular injection changes absorption, hurts more and bruises more, and needs a longer needle. Some medications (testosterone cypionate, for example) are different, but that is a separate instruction from your clinician.

+−What if I see blood after injecting?

A drop of blood means the needle nicked a small capillary. Press with a clean tissue for 30 seconds. A bruise may follow; it is harmless. If you draw back on the plunger and see blood in the syringe before injecting, withdraw, discard that syringe and use a fresh one at a new spot. Most clinicians no longer recommend aspirating for subcutaneous injections at all.

+−Can I reuse a needle or syringe?

No. A needle dulls and bends on first use, which makes the next injection hurt more and tear tissue; it also carries bacteria into the vial. Needle reuse is one of the two main causes of lipohypertrophy, the fatty lumps that develop at injection sites. One syringe, one needle, one injection.

+−Why do I get lumps or hard spots where I inject?

Repeated injections into the same small area cause lipohypertrophy, a rubbery thickening of fat under the skin. It is extremely common in people who inject insulin and is strongly associated with not rotating sites and with reusing needles. Drug injected into a lump is absorbed erratically. The fix is a rotation plan and a fresh needle each time; established lumps take months to resolve and should not be injected into.

+−What angle should I use?

90 degrees (straight in) with a 4 to 6 mm needle. With an 8 mm syringe needle, or in a lean person or a child, lift a fold of skin and inject straight into the fold, or use a 45-degree angle. The old 12.7 mm (half-inch) insulin needle is no longer recommended for most people because it reaches muscle.

+−How far apart should injections be?

At least 1 cm (about half an inch) from the previous injection, and most clinicians suggest an inch. Work through a zone systematically, for example clockwise around the abdomen, so you do not return to the same spot for several weeks.

Sources

1. LabelNovo Nordisk. Wegovy (semaglutide) injection: prescribing information, section 2 (administration: abdomen, thigh or upper arm; rotate injection sites) and section 6 (injection site reactions) (DailyMed).
2. LabelEli Lilly. Zepbound (tirzepatide) injection: prescribing information, sections 2 and 6 (DailyMed).
3. GuidelineFrid AH et al. New insulin delivery recommendations (FITTER international consensus). Mayo Clin Proc 2016;91:1231-55. (2016)
4. StudyBlanco M et al. Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes. Diabetes Metab 2013;39:445-53. (2013)
5. GuidelineGuo L et al. Consensus recommendations on lipohypertrophy: insights from an international panel of experts. Diabetes Res Clin Pract 2026. (2026)
6. GuidelineCDC. Injection safety: clinical safety guidance for healthcare providers. Reviewed March 2024. (2024)
7. RegulatoryFDA. Safely using sharps (needles and syringes) at home, at work and on travel.